Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-06-01 16:01:41 ET · period of report 2026-05-28 · accession 0001536639-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-01 16:01 | 2026-05-28 | JAZZ | Mulligan Seamus | Dir | M - OptEx | $138.08 | +3,415 | 1.18M | +0.3% | +$471.5K |
| D | 2026-06-01 16:01 | 2026-05-28 | JAZZ | Mulligan Seamus | Dir | M - OptEx | $0.00 | -3,415 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-28 | M | A | 3,415 | $138.08 | 1,183,028 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-05-28 | M | D | 3,415 | $0.00 | 0 | D | $138.08 · — to 2026-08-10 | 3,415 Ordinary Shares | (F2) This non-qualified stock option was granted on August 11, 2016 and vested over the period from September 1, 2016 through August 1, 2017. The options were fully vested as of August 1, 2017. |